News & Comment

AIDS: A Justifiable Share

See allHide authors and affiliations

Science  18 Apr 1997:
Vol. 276, Issue 5311, pp. 345
DOI: 10.1126/science.276.5311.345

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Lobby groups pushing for more funding for research on specific diseases often compare their share of the National Institutes of Health's (NIH's) budget to the $1.5 billion being spent on AIDS. But NIH officials counter that the spending on AIDS is justified on the basis of the impact of the disease, scientific opportunities, and the chance to reduce expenditures on AIDS in the long term, as has happened with many other infectious diseases.